- Home
- GMGI vs VYGR Comparison
GMGI vs VYGR Comparison
Compare GMGI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- VYGR
- Stock Information
- Founded
- GMGI 2008
- VYGR 2013
- Country
- GMGI United States
- VYGR United States
- Employees
- GMGI N/A
- VYGR N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- VYGR Health Care
- Exchange
- GMGI Nasdaq
- VYGR Nasdaq
- Market Cap
- GMGI 193.9M
- VYGR 206.9M
- IPO Year
- GMGI N/A
- VYGR 2015
- Fundamental
- Price
- GMGI $1.01
- VYGR $4.18
- Analyst Decision
- GMGI Strong Buy
- VYGR Strong Buy
- Analyst Count
- GMGI 1
- VYGR 7
- Target Price
- GMGI $4.00
- VYGR $14.50
- AVG Volume (30 Days)
- GMGI 402.2K
- VYGR 654.2K
- Earning Date
- GMGI 11-12-2025
- VYGR 11-11-2025
- Dividend Yield
- GMGI N/A
- VYGR N/A
- EPS Growth
- GMGI N/A
- VYGR N/A
- EPS
- GMGI N/A
- VYGR N/A
- Revenue
- GMGI $172,818,124.00
- VYGR $42,580,000.00
- Revenue This Year
- GMGI $25.43
- VYGR N/A
- Revenue Next Year
- GMGI $13.00
- VYGR $107.07
- P/E Ratio
- GMGI N/A
- VYGR N/A
- Revenue Growth
- GMGI 54.66
- VYGR N/A
- 52 Week Low
- GMGI $0.93
- VYGR $2.65
- 52 Week High
- GMGI $3.06
- VYGR $8.28
- Technical
- Relative Strength Index (RSI)
- GMGI 33.93
- VYGR 62.05
- Support Level
- GMGI $0.93
- VYGR $3.91
- Resistance Level
- GMGI $1.08
- VYGR $4.37
- Average True Range (ATR)
- GMGI 0.12
- VYGR 0.27
- MACD
- GMGI -0.01
- VYGR 0.07
- Stochastic Oscillator
- GMGI 12.64
- VYGR 73.33
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.